Itch: More than skin deep

International Archives of Allergy and Immunology

Volumn 135, Issue 2, 2004, Pages 166-172

  Greaves, Malcolm W ^a,b   Khalifa, Nedha ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Itch; Mediators; Opioid peptides; Tickle; Treatment of itch

Indexed keywords

ANALGESIC AGENT; CALAMINE; DOXEPIN; EMOLLIENT AGENT; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MIRTAZAPINE; MU OPIATE RECEPTOR ANTAGONIST; NALBUPHINE; NALOXONE; ONDANSETRON; OPIATE; OPIATE ANTAGONIST; OPIATE PEPTIDE; PAROXETINE;

CHOLESTASIS; GLAUCOMA; HUMAN; MAST CELL; NERVE ENDING; NOCICEPTIVE RECEPTOR; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PRURITUS; REVIEW; SEDATION; SIDE EFFECT; SKIN CELL; ULTRAVIOLET B RADIATION; XEROSTOMIA;

HUMANS; MAST CELLS; NEURAL PATHWAYS; NOCICEPTORS; PRURITUS; SIGNAL TRANSDUCTION; SKIN PHYSIOLOGY;

EID: 5744242306     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080898     Document Type: Review

References (55)

1. Twycross R, Greaves MW, Handwerker H, Jones EA, Libretto SE, Szepietowski JC, Zylicz Z: Itch: Scratching more than the surface. QJM 2003;96:7-26.
2. Yosipovitch G, Greaves MW, Schmelz M: Itch. Lancet 2003;361:690-694.
3. Stander S, Steinhoff M, Schmelz M, Weisshaar E, Metze D, Luger T: Neurophysiology of pruritus. Arch Dermatol 2003;139:1463-1470.
4. Yosipovitch G, Greaves MW, Mc Glone F, Fleischer AB: Itch: Basic Mechanisms and Therapy. New York, Marcel Dekker, 2004.
5. Darsow U, Scharein E, Simon D, Walter G, Bromm B, Ring J: New aspects of itch pathophysiology: Component analysis of atopic itch using the Eppendorf Itch Questionnaire. Int Arch Allergy Immunol 2001;124:326-331.
6. Bergasa NV, Talbot DL, Alling DW, Schmitt JM, Walker EF, Baker BL, Korenman JC, Park Y, Hoofnagle JH, Jones EA: A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 1992;102:544-549.
7. 2O positron emission tomography studies. Pain 2001;92:295-305.
8. Mc Glone F, Rukweid R, Hitchcock D, Howard M: Histamine-induced discriminative and affective responses revealed by functional MRI; in Yosipovitch G Greaves MW, Mc Glone F, Fleischer AB (eds): Itch: Basic Mechanisms and Therapy. New York, Marcel Dekker, 2003, pp 53-62.
9. Schmelz M: A neural pathway for itch. Nat Neurosci 2001;4:9-10.
10. Schmelz M, Hilliges M, Schmidt RO, Orstavik K, Vahlquist C, Weidner C, Handwerker HO, Torebjork HE: Active itch fibres in chronic pruritus. Neurology 2003;26:564-566.
11. Andrew D, Craig AD: Spinothalamic lamina 1 neurons selectively sensitive to histamine: A central neural pathway for itch. Nat Neurosci 2001;4:72-77.
12. Krause L, Shuster S: Mechanism of action of anti-pruritic drugs. Br Med J 1983;287:1199-1200.
13. Rukweid R, Lischetzki G, McGlone F, Heyer G, Schmelz M: Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: A dermal microdialysis study. Br J Dermatol 2000;142:1-8.
14. Steinhoff M, Vergnolle M, Young SH, Tognetto M, et al: Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 2000;6:151-158.
15. Heyer G, Vogelsgang M, Hornstein OP: Acetyl choline is an inducer of itching in patients with atopic eczema. J Dermatol 1997;24:621-625.
16. Jorizzo JL, Coutts A, Eady RAJ, Greaves MW: Vascular responses to injection of substance P and mechanism of action Eur J Pharmacol 1983;87:67-76.
17. Greaves MW, McDonald-Gibson W: Itch: Role of prostaglandins. Br Med J 1973;3:608-609.
18. Andoh T, Kuraishi Y: Intradermal leukotriene B4 but not prostaglandin E2 induces itch-associated responses in mice. Eur J Pharmacol 1998;353:93-96.
19. Wahlgren CF, Scheynius A, Hagermark O: Antipruritic effect of cyclosporin A in atopic dermatitis. Acta Derm Venereol 1990;70:323-329.
20. Ikoma A, Rukwied R, Stander S, Steinhoff M, Miyachi Y, Schmelz M: Neuronal sensitization for histamine-induced itch in lesional skin of patients with atopic dermatitis. Arch Dermatol 2003;139:1455-1458.
21. Twycross R, Greaves MW, Handwerker H, Jones EA, Libretto SE, Szepietowski JC, Zilicz Z: Itch: Scratching more than the surface. QJM 2003;96:7-26.
22. Yosipovitch G, Greaves MW, Schmelz M: Itch. Lancet 2003;361:690-694.
23. Jones EA, Bergasa NV: The pruritus of cholestasis. Hepatology 1999;29:1003-1006.
24. Wallengren J, Klinker M: Successful treatment of notalgia paresthetica with topical capsaicin: Vehicle-controlled double-blind crossover study. J Am Acad Dermatol 1995;32:267-269.
25. Ballantyne JC, Loach AB, Carr DB: Itching after spinal and epidural opiates. Pain 1988;33:149-160.
26. Cohen SE, Ratner EF, Kreitzman TR, Archer JH, Mignano L: Nalbuphine is better than naloxone for treatment of side effects after epidural morphine. Anesth Analg 1992;75:747-752.
27. Bergasa NV, Sabol SL, Yound WS, Kleiner DE, Jones EA: Cholestasis is associated with preproenkephalin mRNA expression in the adult rat liver. Am J Physiol 1995;268:346-354.
28. Khalifa N: PhD thesis, London, 2003.
29. Bergasa NV, Thomas DA, Vergalla J, Turner ML, Jones EA: Plasma from patients with pruritus of cholestasis induces opioid receptormediated scratching in monkeys. Life Sci 1993;53:1253-1257.
30. Jones EA, Neuberger J, Bergasa NV: Opiate antagonist therapy for the pruritus of cholestasis: The avoidance of opioid withdrawal-like reactions. QJM 2002;95:1-6.
31. Kamei J, Nagase H: Norbinaltorphimine, a selective κ-opioid receptor antagonist induces an itch-associated response in mice. Eur J Pharmacol 2001;418:141-145.
32. Togashi Y, Umeuchi H, Okano K: Antipruritic activity of the kappa-opioid receptor agonist TRK-820. Eur J Pharmacol 2002;435:259-264.
33. Kumagai H, Sasamura H, Hayashi M: Prospects for a novel opioid kappa receptor agonist TRK-820 in uraemic pruritus; in Yosipovitch G, Greaves MW, Mc Glone F, Fleischer AB (eds): Itch: Basic Mechanisms and Therapy. New York, Marcel Dekker, 2004, pp 279-286.
34. Kjellberg F, Tramer MR: Pharmacological control of opioid-induced pruritus: A quantitative systematic review of randomised trials. Eur J Anaesthesiol 2001;18:346-357.
35. Wall PD, Melzack R: Textbook of Pain, ed 3. Edinburgh, Churchill Livingstone, 1995.
36. Greaves MW, Wall PD: Pathophysiology of itching. Lancet 1996;348:938-940.
37. Wall PD, Sweet WH: Temporary abolition of pain in man. Science 1967;155:108-109.
38. Melzack R, Wall PD: Pain mechanisms: A new theory. Science 1965;150:971-979.
39. Mintz T: Tickle - the itch that moves. Psychosom Med 1967;29:606-611.
40. Harris CR: The mystery of ticklish laughter. Am Sci 1999;87:344-351.
41. Weiskrantz L, Elliott J, Darlington C: Preliminary observations on tickling oneself. Nature 1971;230:598-599.
42. Fruhstorfer H, Hermanns M, Latzke L: The effects of thermal stimulation on clinical and experimental itch. Pain 1986;24:259-269.
43. Gilchrest BA, Rowe JW, Brown RS: Ultraviolet phototherapy of uremic pruritus: Long-term results and possible mechanisms of action. Ann Intern Med 1979;91:17-21.
44. Lim HW, Vallurupalli S, Meola T, Soter NA: UVB phototherapy is an effective treatment for pruritus in patients infected with HIV. J Am Acad Dermatol 1997;37:414 -417.
45. Baldo A, Sammarco E, Martinelli V, Monfrecola G: UVB phototherapy for pruritus in polycythaemia vera. J Dermatolog Treat 1996;7:245-246.
46. Kaptanoglu AF, Oskay T: Ultraviolet B treatment for pruritus in Hodgkin's lymphoma. J Eur Acad Dermatol Venereol 2003;17:489-490.
47. Figueiredo A, Ribeiro CA, Goncalo M, Almeida L, Poiares-Baptista A, Teixeira F: Mechanism of action of doxepin in the treatment of chronic urticaria. Fundam Clin Pharmacol 1990;4:147-158.
48. Peer G, Kivity S, Agami O: Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 1996;349:1552-1554.
49. Metze D, Reimann S, Beissert S, Luger T: Efficacy and safety of naltrexone, an oral opiate antagonist in the treatment of pruritus in internal and dermatological diseases J Am Acad Dermatol 1999;41:533-559.
50. Cohen SE, Ratner EF, Kreitzman TR, Archer JH, Mignano LR: Nalbuphine is better than naloxone for treatment of side effects after epidural morphine. Anesth Analg 1992;75:747-752.
51. Zylicz Z, Smits C, Chem D, Krajnik M: Paroxetine for pruritus of advanced cancer. J Pain Symptom Manage 1998;16:121-24.
52. Bergeron R, Blier P: Cisapride for the treatment of nausea produced by selective serotonin reuptake Inhibitors. Am J Psychiatry 1994;151:1084-1086.
53. Schworer H, Hartman H, Ramadori G: Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5HT3) receptor antagonists: Effectiveness of odansetron. Pain 1995;61:33-37.
54. Murphy M, Reaich D, Pai P, Finn P, Carmichael AJ: A randomised placebo-controlled double-blind trial of odansetron in renal itch. Br J Dermatol 2001;145(suppl 59):20-21.
55. Kasper S: Clinical efficacy of mirtazepine: A review of meta-analyses of pooled data. Int Clin Psychopharmacol 1995;10(suppl 4):25-35.